Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    November 2018
  1. SHEN B, Kochhar G, Hull TL
    Bridging Medical and Surgical Treatment of Inflammatory Bowel Disease: The Role of Interventional IBD.
    Am J Gastroenterol. 2018 Nov 21. pii: 10.1038/s41395-018-0416.
    PubMed     Text format    


  2. VERNERO M, Astegiano M, Ribaldone DG
    New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0422.
    PubMed     Text format    


  3. COHEN-MEKELBURG S, Rosenblatt R, Gold S, Shen N, et al
    Fragmented Care is Prevalent among Inflammatory Bowel Disease Readmissions and is Associated with Worse Outcomes.
    Am J Gastroenterol. 2018 Nov 12. pii: 10.1038/s41395-018-0417.
    PubMed     Text format     Abstract available


  4. CROSS RK, Langenberg P, Regueiro M, Schwartz DA, et al
    A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0272.
    PubMed     Text format     Abstract available


  5. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Nov 2. pii: 10.1038/s41395-018-0401.
    PubMed     Text format     Abstract available


    October 2018

  6. Inflammatory Bowel Disease (Abstracts 568-744).
    Am J Gastroenterol. 2018 Oct 25. pii: 10.1038/s41395-018-0296.
    PubMed     Text format    


  7. CHAPARRO M, Gisbert JP
    Pregnancy and Inflammatory Bowel Disease: A Long Way to Go.
    Am J Gastroenterol. 2018 Oct 24. pii: 10.1038/s41395-018-0379.
    PubMed     Text format    


  8. BYE WA, Ma C, Nguyen TM, Parker CE, et al
    Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0354.
    PubMed     Text format     Abstract available


  9. MA D, Wong W, Aviado J, Rodriguez C, et al
    Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0368.
    PubMed     Text format     Abstract available


  10. SCHARL S, Barthel C, Rossel JB, Biedermann L, et al
    Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0360.
    PubMed     Text format     Abstract available



  11. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0312.
    PubMed     Text format    



  12. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0342.
    PubMed     Text format    



  13. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0327.
    PubMed     Text format    


    September 2018
  14. ALMARIO CV, Chen MS, Spiegel BMR
    Reply to Johnson et al. Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Sep 13. pii: 10.1038/s41395-018-0279.
    PubMed     Text format    


  15. NG SC, Kaplan GG, Tang W, Banerjee R, et al
    Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0233.
    PubMed     Text format     Abstract available


    August 2018
  16. JAIRATH V
    Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.
    Am J Gastroenterol. 2018 Aug 29. pii: 10.1038/s41395-018-0224.
    PubMed     Text format     Abstract available


  17. AXELRAD JE, Joelson A, Green PHR, Lawlor G, et al
    Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Aug 3. pii: 10.1038/s41395-018-0211.
    PubMed     Text format     Abstract available


    July 2018
  18. FELD LD, Rubin DT, Feld AD
    Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
    Am J Gastroenterol. 2018 Jul 16. pii: 10.1038/s41395-018-0204.
    PubMed     Text format    


  19. FRIEDMAN S, Magnussen B, O'Toole A, Fedder J, et al
    Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Am J Gastroenterol. 2018 Jul 10. pii: 10.1038/s41395-018-0177.
    PubMed     Text format     Abstract available


  20. JOHNSON FR, Reed S, Gonzalez JM
    Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Jul 3. pii: 10.1038/s41395-018-0186.
    PubMed     Text format    


    June 2018
  21. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0162.
    PubMed     Text format     Abstract available


  22. SINGH S, Proudfoot JA, Dulai PS, Jairath V, et al
    No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0144.
    PubMed     Text format     Abstract available


  23. NHU QM, Chiao H, Moawad FJ, Bao F, et al
    The Anti-alpha4beta7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0145.
    PubMed     Text format    


  24. LEVENSTEIN S, Prantera C
    Depression and Disease Course in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0111.
    PubMed     Text format    


  25. MAO R, Chen MH
    Networked Clinical Study Collaboration on Inflammatory Bowel Disease in China.
    Am J Gastroenterol. 2018 Jun 7. pii: 10.1038/s41395-018-0148.
    PubMed     Text format    


    May 2018
  26. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0057.
    PubMed     Text format     Abstract available


    April 2018
  27. MATSUSHITA M, Fukata N, Omiya M, Nishio A, et al
    Pathophysiology of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:622.
    PubMed     Text format    


    March 2018
  28. JENSEN CB, Angquist LH, Mendall MA, Sorensen TIA, et al
    Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0031.
    PubMed     Text format     Abstract available


  29. DEEKE SA, Starr AE, Ning Z, Ahmadi S, et al
    Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis.
    Am J Gastroenterol. 2018 Mar 12. pii: 10.1038/s41395-018-0024.
    PubMed     Text format     Abstract available


  30. VEERAPPAN GR
    Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018;113:404.
    PubMed     Text format    


    February 2018
  31. DAI C, Jiang M, Cao Q
    Association between Depression and More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0016.
    PubMed     Text format    


  32. CHAPARRO M, Verreth A, Lobaton T, Gravito-Soares E, et al
    Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg2017501. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  33. GRACIE DJ, Hamlin PJ, Ford AC
    Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0021.
    PubMed     Text format     Abstract available


  34. DULAI PS, Buckey JC Jr., Raffals LE, Swoger JM, et al
    Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0005.
    PubMed     Text format     Abstract available


  35. BARNES EL, Kappelman MD
    Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.
    Am J Gastroenterol. 2018;113:273-275.
    PubMed     Text format     Abstract available


  36. TOMINAGA K, Tsuchiya A, Honda Y, Abe T, et al
    A Case of Panenteritis With Massive IgG4-Positive Plasma Cell Infiltration Developed 26 Years After Total Proctocolectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:173.
    PubMed     Text format    


    January 2018
  37. LEWIS JD, Scott FI, Brensinger CM, Roy JA, et al
    Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jan 16. pii: ajg2017479. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  38. JEURING SFG, Biemans VBC, van den Heuvel TRA, Zeegers MP, et al
    Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2018 Jan 9. pii: ajg2017482. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    December 2017
  39. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  40. MA C, Moran GW, Benchimol EI, Targownik LE, et al
    Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.
    Am J Gastroenterol. 2017;112:1840-1848.
    PubMed     Text format     Abstract available


    November 2017
  41. KOCHAR B, Barnes EL, Long MD, Cushing KC, et al
    Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  42. CLICK B, Anderson AM, Koutroubakis IE, Rivers CR, et al
    Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.
    Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  43. BERNSTEIN CN, Kornbluth A
    Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1719-1721.
    PubMed     Text format     Abstract available


  44. ABE K, Nakamura N, Isono A, Toyota H, et al
    Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
    Am J Gastroenterol. 2017;112:1636.
    PubMed     Text format    


    October 2017
  45. MARTIN L, Peche W, Peterson K, Wan Y, et al
    Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available



  46. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  47. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  48. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  49. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    


  50. FISCHER S, Rath T, Geppert CI, Manger B, et al
    Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1621-1623.
    PubMed     Text format    


  51. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


  52. BUCHNER AM, Lichtenstein GR
    Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Am J Gastroenterol. 2017;112:1593-1595.
    PubMed     Text format     Abstract available


  53. KHANNA R, Zou G, Stitt L, Feagan BG, et al
    Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Am J Gastroenterol. 2017;112:1584-1592.
    PubMed     Text format     Abstract available


    September 2017
  54. ESTEVEZ-BOULLOSA P, Fernandez-Fernandez N, Pineda-Marino JR, Martinez-Cadilla J, et al
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1363.
    PubMed     Text format    


  55. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017;112:1485.
    PubMed     Text format     Abstract available


    August 2017
  56. GHIONE S, Sarter H, Fumery M, Armengol-Debeir L, et al
    Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    July 2017
  57. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017 Jul 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  58. YAMADA A, Komaki Y, Patel N, Komaki F, et al
    Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  59. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  60. DAI C, Jiang M, Sun MJ
    The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1165.
    PubMed     Text format    


  61. MATSUSHITA M, Fukata N, Omiya M, Okazaki K, et al
    Nationwide Studies of Hematological Malignancies in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1171-1172.
    PubMed     Text format    


    June 2017
  62. MYRELID P, Landerholm K, Nordenvall C, Pinkney TD, et al
    Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study.
    Am J Gastroenterol. 2017 Jun 27. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  63. PATIL DT, Odze RD
    Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jun 20. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  64. KOMEDA Y, Kashida H, Sakurai T, Kono M, et al
    A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:833.
    PubMed     Text format    


    May 2017
  65. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  66. CHAPARRO M, Ramas M, Benitez JM, Lopez-Garcia A, et al
    Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    April 2017
  67. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    March 2017
  68. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed     Text format    


  69. LIMSRIVILAI J, Shreiner AB, Pongpaibul A, Laohapand C, et al
    Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Am J Gastroenterol. 2017;112:415-427.
    PubMed     Text format     Abstract available


    February 2017
  70. FUMERY M, Seksik P, Auzolle C, Munoz-Bongrand N, et al
    Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Am J Gastroenterol. 2017;112:337-345.
    PubMed     Text format     Abstract available


  71. JEURING SF, van den Heuvel TR, Liu LY, Zeegers MP, et al
    Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2017;112:325-336.
    PubMed     Text format     Abstract available


    January 2017
  72. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  73. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format    


  74. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  75. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed     Text format    


  76. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed     Text format    


  77. CUI DJ, Zhao X, Hu M
    Impact of Crohn's Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2017;112:185.
    PubMed     Text format    


    December 2016
  78. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  79. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed     Text format    


    November 2016
  80. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed     Text format    


    October 2016
  81. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  82. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available



  83. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  84. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  85. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  86. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    


  87. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed     Text format    


  88. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Text format     Abstract available


    June 2016
  89. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed     Text format    


    May 2016
  90. DEEPAK P, Fletcher JG, Fidler JL, Barlow JM, et al
    Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: